Skip to content

NANOSTRING TECHNOLOGIES, INC. NanoString launches the most comprehensive spatial proteomics panel ever

NanoString launches the most comprehensive spatial proteomics panel ever Equipped with Abcam’s IHC-validated antibodies for cancer
immunotherapy research, enables simultaneous spatial profiling of over 500 proteins in FFPE tissue.
We will be introducing the GeoMx IO Proteome Atlas (IPA), which will redefine traditional proteomics research, at the 82nd Annual Meeting of the Japanese Cancer Society, which will be held at Pacifico Yokohama from September 21st.
[Table 3: ]
SEATTLE, September 13, 2023 – (BUSINESS WIRE) — NanoString
Technologies, Inc. (Nasdaq: NSTG, hereinafter referred to as NanoString) is a leading company that provides technologies for basic and translational research in the life sciences field. ) today announced the launch of its latest assay for the GeoMx(R) Digital Spatial Profiler (DSP) Announced. GeoMx IO Proteome Atlas (IPA)
Although the GeoMx IPA panel is aimed at IO research, it can be used in a wide range of research areas beyond cancer, including infectious diseases, organ transplantation, autoimmunity, metabolism, and epigenetics.
Here’s what the GeoMx IPA Assay can do for you:
Simplify your search for new protein biomarkers and drug targets with unprecedented hyperplex analysis capability to spatially profile FFPE tissue for over 500 Abcam IHC-validated IO antibodies in a single assay Achieved. Antibodies can also be used individually for single target or small plex analysis.
Obtain more comprehensive biological information from valuable tissue specimens than traditional immunohistochemistry (IHC) and
immunofluorescence (IF) methods.
Expression profiling of over 500 protein targets can be performed from a single FFPE tissue section, leading to the discovery of new drug targets in the IO area.
GeoMx IPA and GeoMx WTA can be used together for spatial proteogenomic analysis on the same slide to profile the entire human transcriptome and IO proteome on a single slide.
The GeoMx IPA Assay is available for pre-order and is expected to begin shipping in Q4 2023.
Click here for details on the GeoMx Digital Spatial Profiler, a platform for GeoMx IPA assays. [Inquiries regarding this matter] NanoString Technologies
[Table 4: ]
[Image:×630.png ]
About NanoString Technologies
NanoString is a leading spatial biology company, helping customers expand the horizons of biology by providing an ecosystem of innovative solutions for basic and translational research. GeoMx® Digital Spatial Profiler is a flexible and consistent solution featured in over 160 peer-reviewed papers that combines the benefits of whole tissue specimens with genetic and protein data in a single FFPE slide. Perform spatial whole transcriptome and proteomic analysis. The CosMx(TM) Spatial Molecular Imager is a single-cell imaging platform that utilizes spatial multi-omics and can analyze FFPE samples.By performing single-cell mapping in the natural environment, deep biological knowledge and new discoveries are possible. can be obtained in one experiment. The AtoMx spatial bioinformatics platform is a cloud-based informatics solution with advanced analysis and global collaboration capabilities, allowing you to gain useful insights for spatial biology research anytime and anywhere. The nCounter(R) analysis system, which is the foundation of our various research instruments, has been featured in over 7,000 peer-reviewed papers and has been used to analyze the expression of hundreds of genes, proteins, miRNAs, and copy number variations. It can be done safely and easily, and with high sensitivity and precision. For more information, please visit our website (
The NanoString logo, NanoString, NanoString Technologies, GeoMx, CosMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in the United States and/or other countries.
More details about this release:

%d bloggers like this: